Nandrolone vs Winstrol
FDA Approved vs Well Studied
avoid Mechanism-based · 64% Both Nandrolone and Winstrol carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently.
Molecular Data
Nandrolone Winstrol
Weight 274.40 Da (base) 328.49 Da
Half-life ~6-12 days (decanoate) ~9 hours (oral), ~24 hours (injectable)
Type 19-nortestosterone steroid (C18H26O2) 17-alpha-alkylated anabolic-androgenic steroid (C21H32N2O)
Key Benefits
Nandrolone
01 Significant increases in lean muscle mass with a favorable anabolic-to-androgenic ratio
02 Enhanced collagen synthesis and joint lubrication, reducing joint pain and improving connective tissue integrity
03 Increased bone mineral density through direct osteoblast stimulation
04 Improved nitrogen retention and protein synthesis for accelerated recovery
05 Stimulation of erythropoietin production, increasing red blood cell mass and oxygen delivery
06 Lower androgenic side effects (hair loss, acne, prostate enlargement) compared to testosterone
07 Clinically demonstrated efficacy in treating anemia of chronic renal failure
08 Potential neuroprotective properties observed in preclinical research
Winstrol
01 Produces a dry, hard, and vascular appearance without water retention
02 Significant strength increases without proportional weight gain, favored in weight-class sports
03 Does not aromatize to estrogen, eliminating gynecomastia and bloating concerns
04 Potent suppression of SHBG, increasing free testosterone and enhancing the effectiveness of stacked compounds
05 Available in both oral and injectable formulations
06 High anabolic-to-androgenic ratio (320:30) relative to methyltestosterone
07 FDA-approved for hereditary angioedema prophylaxis
08 Enhances vascularity and muscle definition during caloric deficit
Dosing Protocols
Nandrolone
100-200 mg/week (therapeutic) / 1x per week (decanoate) or 2-3x per week (NPP)
TRT Adjunct - Joint Support 50-100 mg/week 1x per week (decanoate)
Therapeutic - Anemia / Wasting 100-200 mg/week 1x per week (decanoate)
Performance Enhancement - Moderate 200-400 mg/week 1x per week (decanoate) or split into 2 injections
NPP Protocol - Shorter Cycle 200-350 mg/week Every other day or 3x per week
Winstrol
25-50 mg/day (oral), 50 mg EOD (injectable) / Daily (oral) or every other day (injectable)
Performance - Standard Injectable 50 mg every other day Every other day (EOD)
Side Effects
Nandrolone
Suppression of natural testosterone production (profoundly suppressive, more so than testosterone alone)
Water retention and bloating (less than testosterone at equianabolic doses)
Erectile dysfunction and reduced libido without concurrent testosterone ('deca dick')
Increased appetite and weight gain
Mild acne and oily skin (less pronounced than testosterone)
Elevated hematocrit and hemoglobin (erythrocytosis)
Injection site pain or discomfort
Mild mood changes (some users report increased emotional sensitivity)
Winstrol
Severe HDL cholesterol suppression (winstrol is among the worst oral steroids for lipid damage)
Significant LDL cholesterol elevation
Joint dryness and pain, particularly in knees, shoulders, and elbows (notorious side effect)
Hepatic stress with elevated liver enzymes (ALT/AST)
Suppression of endogenous testosterone production
Hair loss and accelerated male pattern baldness (DHT derivative, particularly harsh on hairline)
Acne and oily skin
Tendon and ligament stress due to rapid strength gains combined with reduced joint lubrication
Dry, painful shin splints during cardiovascular exercise
Contraindications
Prostate cancer (active or history of hormone-sensitive prostate cancer)
Breast cancer in males or females
Pregnancy or potential for pregnancy (Category X - causes virilization of female fetus)
Nephrosis or the nephrotic phase of nephritis
Severe hepatic impairment
Hypercalcemia
Known hypersensitivity to nandrolone or any formulation components
Polycythemia (hematocrit above 54% at baseline)
Uncontrolled heart failure or severe cardiovascular disease
Known or suspected prostate cancer
Breast cancer in males
Breast cancer with hypercalcemia in females
Pregnancy (Category X - known to cause fetal harm)
Severe hepatic dysfunction or active liver disease
Nephrosis or nephrotic phase of nephritis
Pre-existing severe cardiovascular disease or dyslipidemia
Hypersensitivity to stanozolol or any formulation component
Research Evidence
Nandrolone Winstrol
Status FDA Approved Well Studied
References 5 studies 5 studies
Latest April 2005 June 2023
FDA Approved Yes Yes
This comparison is for educational and research purposes only. Consult a healthcare professional before use.